cerrar
Tagged with Europe,

Oncology Care in Hungary: In Need of Reform
Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country's innovative pharma association has…

Christoph Stoller – President & Adrian van den Hoven…
Christoph Stoller, the recently appointed president of Medicines for Europe, outlines the mission of his presidency, how the association and its…

Germany: The Essential Requirements on Trading Medical Cannabis…
Dentons Germany's Peter Homberg outlines the key requirements that companies need to fulfil in order to import medical cannabis into Germany and how…

Proposed Solutions to the Access Challenges Facing Cancer…
Janssen's EMEA market access head Martin Price outlines the regulatory changes that need to be made for patients across Europe to better access…

Europe’s Enduring Importance for Janssen
PharmaBoardroom recently sat down with Janssen EMEA head Kris Sterkens, who outlined the enduring importance of Europe to the global group, even with…

European MidPharmas: Focused and Resilient, yet Vulnerable
European MidPharmas – R&D based pharmaceutical companies with annual revenues of between EUR 50 million and 5 billion – are having to be…

Europe: Political Complexity Bodes Poorly for Pharma
Aditya Bhattacharji takes a look at the potentially damaging impact of political uncertainty across Europe - including the impending exit of the UK…

Top European Pharma Mid-Cap Ranking 2019
The European MidPharma Performance Ranking 2019 is taken from The Novasecta European Midpharma Report 2019, which examines how European mid-cap pharma…

East vs West: Bridging the Access Gap in European Cancer Care
From her vantage point as associate vice president for MSD's Central & Eastern Europe (CEE) cluster, Gabriele Grom outlines the disparity that…

5 Top European Mid-Cap CEOs To Know
Bringing together insights from the heads of some of Europe's most prominent mid-cap pharma firms. The leaders of Ipsen, Genmab, Pierre Fabre, Esteve…

The European Medicines Verification System Launches to Tackle…
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use cutting-edge technology to safeguard the…

Adrian van den Hoven – Director General, Medicines for…
Over the last ten years, generic medicines have increased access to medicines by over 100% in 7 key therapeutic areas and have provided massive…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here